Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Meningitis Group Urges Earlier Sale Of Approved Sanofi Pasteur Vaccine

This article was originally published in PharmAsia News

Executive Summary

At a press briefing held at the Ministry of Health, Labor and Welfare Feb 8, Miki Tanaka, president of Guiding Children From Bacterial Meningitis, called for earlier sale of preventative vaccines and expressed dismay at the time taken to put Sanofi Pasteur's Hib vaccine on the market. Approved in Japan in January 2007, the vaccine is still not available. A patient and doctor advocacy group presented MHLW with a petition for Hib vaccine regular inoculations and an earlier approval of pneumococcal vaccination for children. (Click for more - Japanese language
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC067655

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel